DTX2 and hepatocellular carcinoma: Knockdown of DTX2 in HCC cells resulted in a decrease in the transcript level of PD‐L1, which was identified as a marker for immunosuppressive neutrophils in a previous study.[26] This finding suggested that targeting DTX2 might attenuate the immunosuppressive characteristics of the immune microenvironment.